ProfileGDS4095 / 202346_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 95% 94% 95% 95% 94% 95% 96% 95% 95% 95% 95% 95% 95% 95% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep111.657595
GSM709769LY2 SRC1-siRNA tamoxifen treated rep311.470894
GSM709765LY2 SRC1-siRNA untreated rep311.727795
GSM709771LY2 SRC1-siRNA untreated rep111.540695
GSM709772LY2 SRC1-siRNA untreated rep211.497994
GSM709775LY2 SRC1-siRNA untreated rep411.615195
GSM709764LY2 control-siRNA tamoxifen treated rep211.827596
GSM709766LY2 control-siRNA tamoxifen treated rep311.721895
GSM709768LY2 control-siRNA tamoxifen treated rep111.634395
GSM709777LY2 control-siRNA tamoxifen treated rep411.569495
GSM709770LY2 control-siRNA untreated rep311.53295
GSM709773LY2 control-siRNA untreated rep111.606395
GSM709774LY2 control-siRNA untreated rep211.586795
GSM709776LY2 control-siRNA untreated rep411.678795